Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development
- 12 October 2009
- Vol. 28 (1) , 38-47
- https://doi.org/10.1016/j.vaccine.2009.09.126
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The Immunogenetics of Smallpox VaccinationThe Journal of Infectious Diseases, 2007
- Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpoxClinical and Experimental Immunology, 2007
- Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometryNature Methods, 2007
- The contributions of mass spectrometry to understanding of immune recognition by T lymphocytesInternational Journal of Mass Spectrometry, 2007
- A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virusNature Biotechnology, 2006
- Identification of Class II HLA-DRB1*03-Bound Measles Virus Peptides by 2D-Liquid Chromatography Tandem Mass SpectrometryJournal of Proteome Research, 2005
- Identification and Characterization of Novel, Naturally Processed Measles Virus Class II HLA-DRB1 PeptidesJournal of Virology, 2004
- Reliable prediction of T‐cell epitopes using neural networks with novel sequence representationsProtein Science, 2003
- Towards patient‐specific tumor antigen selection for vaccinationImmunological Reviews, 2002
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002